Diagnostics facilitate preventive measures, such as lifestyle changes or prophylactic treatments, which can prevent the onset of chronic diseases and reduce long-term healthcare costs. They also enable the customization of treatments to individual patients' needs, improving the effectiveness of therapies and overall healthcare economics. Join industry experts Elliott Greenspan, CIO and Co-Founder, Igentify, Lishan Aklog, MD, Chairman and CEO, Lucid Diagnostics, Rollie Carlson, CEO, Immunexpress Inc. and Mike Ward, Head of Thought Leadership for Life Sciences & Healthcare, Clarivate, as they discuss the latest innovations in the field of diagnostics. Watch our on-demand webinar 'New frontiers in diagnostics: opportunities and challenges post-pandemic' to learn more on the potential impact of diagnostics on the industry: https://lnkd.in/d7fxfkN7 #MedTech #Diagnostics #healthcareeconomy
About us
Think forward™ to a healthier tomorrow. Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. Our connected data, deep expertise and intelligence platforms empower life sciences and healthcare companies to deliver safe, effective and commercially successful treatments to patients faster. Clarivate is home to Cortellis™, solutions for real world data, medtech, market access and commercialization and deep consulting expertise. About Clarivate Clarivate™ is a global leader in providing trusted information and insights to accelerate the pace of innovation. We offer subscription and technology-based solutions coupled with deep domain expertise that cover the entire lifecycle of innovation – from foundational research and ideas to protection and commercialization. Today, we’re setting a trail-blazing course to help customers turn bold ideas into life-changing inventions. Our portfolio consists of some of the world’s most trusted information brands, including the Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor™ and Publons™. For more information, please visit clarivate.com.
- Website
-
https://clarivate.com/industries/life-sciences-and-healthcare/
External link for Clarivate for Life Sciences & Healthcare
- Industry
- IT Services and IT Consulting
- Company size
- 10,001+ employees
- Specialties
- pharmaceuticals, biopharma, pharma, and medtech
Updates
-
Tallac Therapeutics with next-generation ADC technology, is one of the seven innovative companies listed in the Clarivate Companies to Watch report this year. The company's novel antibody-oligonucleotide conjugation technology underpins its pipeline of immunotherapy candidates. These candidates provide targeted immune activation within the tumor microenvironment using a potent Toll-like receptor (TLR9) agonist (T-CpG). Why is Tallac Therapeutics a company to watch? Download the report to discover innovations transforming drug discovery and development, revolutionizing cancer treatment, and capturing big pharma interest, here: https://lnkd.in/eCSaAWtu #oncology #cancertreatement #biotech #pharma #companiestowatch
-
-
With interest rates rising to counter inflation, the environment is ripe for a resurgence of MedTech deals and M&As in 2024. Macro trends, such as an aging global population, increasing access to healthcare, and technological advances, are setting the stage for further innovation and investment in this space. Clarivate analysts identify the deals in MedTech and five key MedTech trends in 2024: shifts in sites of service, AI in MedTech, the impact of GLP-1 receptor agonists, supply chain and regulatory changes in Mainland China. The report is the second installment in a two-part series offering a predictive analysis of emerging trends shaping the MedTech industry. Learn more: https://lnkd.in/ed96arGe #MedicalTechnologiesToWatch #MedicalDevices #Medtech #MedicalTechnology
-
-
With our unmatched pipeline coverage, spanning drugs from the early preclinical phase to launched drugs, gain the insights you need to build an intelligent portfolio with Cortellis Drug discovery intelligence. Identify new business opportunities with detailed RoS (Route of Synthesis) information for various APIs and API intermediates, unveil new revenue streams and supply partnerships. Learn more: https://lnkd.in/ds3AKWFf #patent #API #drugdiscovery
-
-
Double-digit growth is projected for the contract market for antibody drug conjugates (ADCs). Increased investment by both large bio/pharma companies and smaller ADC innovators is fueling demand for for high-potency manufacturing and conjugation services. Which companies lead the charge? Read the article by DCAT (Drug, Chemical & Associated Technologies Association) Value Chain Insights featuring data and insights from this year's Clarivate Companies to Watch report here: https://lnkd.in/dJADY9px #oncology #cancertreatement #biotech #pharma #companiestowatch
-
Pheon Therapeutics, aiming to extend the benefit of ADCs to more patients through novel oncology targets and proprietary linker-payload technologies, is one of the seven innovative companies listed in the Clarivate Companies to Watch report this year. The company's methodical approach to ADC development leverages its suite of in-house and in-licensed technology platforms to generate ADC constructs that are optimized for safety and efficacy for each target to treat a wide range of hard-to-treat cancers. Why is Pheon Therapeutics a company to watch? Download the report to discover innovations transforming drug discovery and development, revolutionizing cancer treatment, and capturing big pharma interest, here: https://lnkd.in/eCSaAWtu #oncology #cancertreatement #biotech #pharma #companiestowatch
-
-
The Clarivate Life Sciences & Healthcare Consulting team recently hosted a pivotal roundtable, bringing together industry leaders and representatives from pharmaceutical companies and trade associations to discuss strategies and solutions for overcoming barriers to innovative therapies. A special thank you to our esteemed speakers: Ken Walsh, Sophie Doran, and Laurie DiModica for their insights on Optimising Access. Alison Isherwood for her impactful presentation on Reducing Disparities and Health Inequity. Sarah Knight and Helen Kitchen for leading the discussion on Driving Patient Outcomes. Jasmine Carlson and Gaia G. for sharing compelling data and insights that reinforced our key findings. Download the whitepaper to explore key highlights from the discussion on succeeding with advanced therapies in Europe. Discover strategies to enhance patient access, reduce health inequality, and drive patient outcomes, here: https://lnkd.in/ejTdfqKN #PatientCare #Pharma #LifeSciences #Healthcare #Innovation #AdvancedTherapies #PatientAccess #HealthEquity
-
-
BioWorld News published by Clarivate , has been honored with nine 2024 Apex Awards for Publication Excellence, underscoring its mission to deliver superior journalistic excellence, data-driven analysis and cutting-edge digital publishing. “This recognition from the APEX Awards is a testament to our team’s unwavering dedication to journalistic excellence. In a fast-paced and ever-changing industry, BioWorld remains a leader through our insightful analysis and compelling storytelling, providing crucial insights into the development of therapeutics and devices, the companies driving these innovations, the business deals shaping the market, and the regulatory challenges that safeguard the process. We are proud to be at the forefront of delivering critical information that drives innovation and improves lives worldwide.” quotes Lynn Yoffee, Publisher, BioWorld. With over 1,100 entries this year, the competition was fierce, making these nine wins a testament to the continued leadership and innovation in the field by BioWorld. Read more: https://lnkd.in/e8_JRiPY #BioWorld #award #journalism #healthcare Annette Marie Boyle, Nuala Moran, Jennifer Boggs, Karen Carey, Anette Breindl, Mari Serebrov, Lee Landenberger, Harini Mathavan, Randy Osborne, Caroline Richards, Tamra Sami, Ann Marie Griffith, Amanda Lanier, Ann Marie Griffith, Amanda Lanier, Mari Serebrov, Anette Breindl, Karen Carey
-
-
As GLP-1 receptor agonists offer a non invasive option for weight management, they are often more appealing than bariatric surgery in the aesthetics and orthopaedics market. However, it is expected that the impact on the U.S. obesity intervention market will likely be more significant in the short term. Clarivate analysts identify the impact of GLP-1 receptor agonists and five breakthrough MedTech trends in 2024: shifts in sites of service, AI in MedTech, deals in MedTech, supply chain and regulatory changes in Mainland China. The report is the second installment in a two-part series offering a predictive analysis of emerging trends shaping the MedTech industry. Learn more: https://lnkd.in/ed96arGe #MedtechTrendsToWatch #Medtech #GLP1 #obesity #weightloss #marketaccess
-
-
The push for diagnostics in the era of remote healthcare has been a game-changer, allowing for better tracking and tailored treatments based on specific variants. This has revolutionized the approach healthcare providers take in telemedicine and has paved the way for precision medicine. Join industry experts Elliott Greenspan, CIO and Co-Founder, Igentify Lishan Aklog, MD, Chairman and CEO, Lucid Diagnostics, Rollie Carlson, CEO, Immunexpress Inc. and Mike Ward, Head of Thought Leadership for Life Sciences & Healthcare, Clarivate, as they discuss these innovations. Watch our on-demand webinar, New Frontiers in Diagnostics, to learn more in our Medtech Resource Center: https://lnkd.in/d7fxfkN7 #MedTech #Diagnostics #chronic #telemedicine #precisionmedicine #webinar